[DNLI] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 20.70%
YoY- -30.79%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 5,847 3,604 4,672 13,604 4,197 4,205 125,676 -87.08%
PBT -58,679 -56,898 -53,950 -46,373 -58,650 -38,992 77,533 -
Tax 79 -135 75 -113 -313 0 -2,379 -
NP -58,758 -56,763 -54,025 -46,260 -58,337 -38,992 77,533 -
Tax Rate - - - - - - 3.07% -
Total Cost 64,605 60,367 58,697 59,864 62,534 43,197 48,143 21.68%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -1,004.93 -1,575.00 -1,156.36 -340.05 -1,389.97 -927.28 61.69 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.56 -0.55 -0.57 -0.48 -0.61 -0.41 0.82 -
EPS Diluted -0.56 -0.55 -0.56 -0.48 -0.61 -0.41 0.79 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.